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Abstract
Objectives. This cross-sectional study examines to
whom and how fully sickle cell disease (SCD)
patients talk to others about sickle cell pain, how
helpful it is to talk with others about these pain
episodes, and the association between talking to
others about sickle cell pain episodes and patients’
psychological adjustment and coping strategies in
managing the disease.
Methods. A convenience sample of 73 African
American patients with SCD (30 men and 43
women), were recruited from two SCD clinics at the
time of routine medical visits. Most participants had
been diagnosed with hemoglobin SS, and they
reported an average number of 8.61 pain episodes in
the previous 12 months. Participants were asked to
whom, how fully, and how helpful it was to talk to
significant others about SCD pain episodes experi-
enced in the last 12 months. Patients also completed
measures of their psychological adjustment as well
as how they would manage a future sickle cell pain
episode. Self-report ratings were made on Likert-
type scales.
Results. Based on paired samples t-tests, partici-
pants talked significantly more fully about their
thoughts and feelings concerning pain episodes to
God and to their primary medical providers than to
either their parents, siblings, or an intimate partner/
close friend. Bivariate correlations indicated that
amount and helpfulness of talking about pain epi-
sodes to God and to parents were significantly asso-
ciated with better psychological adjustment on
selected measures. Also, bivariate correlations indi-
cated that helpfulness in talking with siblings, inti-
mate partner/close friend, and primary medical
providers was positively related with willingness to
go to a physician in the event of a future pain
episode.
Conclusions. The results document to whom and
how helpful it is to talk with others about SCD pain
episodes and how SCD disclosure is related to strat-
egies for managing this disease.
Key Words. Sickle Cell Disease; Talking with Others
about SCD; SCD Self-Disclosure; Psychological
Adjustment; Pain Management
Introduction
Sickle cell disease (SCD) is a serious genetic disorder
found in people whose ancestors originated in Africa,
Mediterranean Europe, Asia, the Pacific Islands, or the
Middle East. It is estimated that about 1,000 babies are
born each year in the United States with SCD, and cur-
rently, there are approximately 89,000 people in the United
States with this disease. Although different racial and
ethnic groups are affected by SCD, African Americans
represent the largest number of individuals with SCD in the
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United States [1,2]. The disorder is characterized by easily
deformed red blood cells that hemolyze (i.e., breakdown)
quickly, causing anemia and blocking of small blood
vessels (termed vascular occlusion). Vascular occlusion
and subsequent inflammation, in turn, can lead to different
sequelae, including gallbladder, liver, and kidney dysfunc-
tion along with heart failure, lung disease, and character-
istic bone changes [3–5]. Some patients have an acute
exacerbation of the disease characterized by bone pain
and fatigue several times per year, but many have pain
episodes as often as every day [6].
Modern advances have extended life expectancy for
patients with SCD. For instance, in the most frequent type
of SCD, hemoglobin SS (HbSS) or sickle cell anemia
patients can expect to live to 42–48 years. Patients with
the second most frequent type of SCD, hemoglobin SC
(HbSC), may live to 60–80 years. These life expectancies
are a marked improvement compared with the 1960s and
1970s when life expectancy was just 14 years [7–11]. The
improvement in life expectancies for SCD patients,
however, comes at a cost to many disease sufferers. SCD
patients who survive into adulthood may experience sig-
nificant organ damage and suffer from multiple chronic
diseases [9]. The financial cost incurred for medical care of
SCD patients who survive into adulthood is also enor-
mous. In 2009, the estimated discounted lifetime health
care costs for a patient with SCD reaching age 45 were
$460,151 [12].
Despite an increase in life expectancy associated with
improvements in medical treatments, psychological and
social factors play an important role in SCD patients’
quality of life as well as in how well they cope with this
disease [13]. For instance, a study of 308 SCD patients
from Richmond and Hampton Roads, Virginia, found that
their health-related quality of life was similarly low to
hemodialysis patients on emotional and physical problems
interfering with everyday life activities and social function-
ing [14]. Also, research indicates psychological states,
such as stress and depression, are associated with more
frequent pain episodes and more severe symptoms [15–
17]. Coping strategies are related to self-care activities
such as taking in fluids, resting, and seeking assistance for
pain episodes [18]. Religion and spirituality (e.g., church
attendance, prayer, and Bible study) are also related to
SCD patients’ appraisal of pain [19,20].
There are numerous studies focusing on family functioning
and peer relationships in coping with chronic pain related
to, for instance, daily headaches, fibromyalgia, and cancer
pain [21–23]. However, there is limited research on the role
of interpersonal and communication factors affecting living
with SCD [24,25]. Nevertheless, consistent with the stress
buffering hypothesis [26], social factors are expected to
promote positive mental and health outcomes for SCD
patients by influencing reactions to disease-related symp-
toms (such as whether or not to seek medical help in
response to a SCD-related pain episode) and how well
patients take care of themselves. We assume that social
interactions and communications with significant others
(such as talking with others about sickle cell pain epi-
sodes) may provide social support and assist individuals
to manage and to live a better quality of life with this
disease. In our view, “who” SCD patients talk to about
SCD as well as the helpfulness of these interactions may
influence patients’ psychological adjustment and how
they meet SCD-related challenges such as intermittent
exposure to sickle cell pain episodes.
Many studies that have found an association between
self-disclosure about stressors and health outcomes
focus on what is termed expressive self-disclosure. In the
research paradigm for expressive self-disclosure, individu-
als are asked to write about their feelings about a stressful
experience in their personal lives, for instance, being
exposed to traumatic events or dealing with a life-
threatening illness. A meta-analysis of 146 studies con-
ducted by Frattaroli [27] found that expressive disclosure
had an r effect size of 0.075 overall across outcome
measures reflecting both physical and psychological func-
tioning. Effects of expressive disclosure were stronger for
measures of psychological adjustment and reported
health than for measures of health behaviors (such as
medication adherence).
Although expressive disclosure is associated with positive
health outcomes, it does not provide evidence about the
social benefits of self-disclosure based on, say, talking
with significant others about major health problems.
Talking with others about health problems may provide
useful information about how to cope with the disease
and/or it may facilitate obtaining tangible support. Talking
to others about one’s health problems may also provide
emotional support, assuming that the disclosure recipient
reacts with acceptance and understanding that, in turn,
increases self-worth and confidence to cope with medical
problems [28–30].
There is extensive research as to whether HIV-positive
patients disclose to others about their HIV positive status
as well as the physical and/or psychological health conse-
quences of HIV disclosure [31,32]. However, this literature
may have limited implications for SCD. With the latter
disease, significant others (such as parents, siblings, and
friends) are likely to know about SCD patients’ disease
status because it is a life-long disease that involves inter-
mittent experiences with pain episodes, medical complica-
tions, and hospital stays. Nonetheless, SCD patients must
make decisions about whether or not to talk with these
others about their medical problems, such as their experi-
ences with sickle cell pain episodes, and talking to signifi-
cant others about such issuesmay be perceived asmore or
less helpful, and that in turn may affect how SCD patients
cope with this disease. Based on these considerations, we
decided to focus in this preliminary study on SCD patients’
decisions about towhomand how fully they talk with others
about experienceswith sickle cell pain, howhelpful it was to
talk with others about these pain episodes, and the asso-
ciation between talking to others about sickle cell pain
episodes and patients’ psychological adjustment and
coping strategies in managing the disease.
1497
Self-Disclosure about Pain Episodes and Living with SCD
Downloaded from https://academic.oup.com/painmedicine/article-abstract/15/9/1496/1893269
by Old Dominion University user
on 02 July 2018
Research Question 1: To Whom and How Fully Do
SCD Patients Talk about Recent Experiences with
Sickle Cell Pain and How Helpful Is It to Talk about
These Pain-Related Events?
We were interested in learning the degree to which SCD
patients talked with significant others (including mother,
father, brother, sister, intimate partner, physician, nurse, or
religious figure such as a minister or priest, and God).
Religion and spiritually based behaviors (including praying
and talking directly with God) have a major place for many
African Americans who are dealing with health-related
problems [19,20,33–36]. God was included as a “disclo-
sure target” for our African American participants, given
that religion and spirituality may play an important role in
coping with health problems, including SCD, for this group
of patients.
Research Question 2: How Is Talking to Others about
Sickle Cell Pain Related to Psychological Adjustment
for SCD Patients?
Although some controversy exists [24], previous research
suggests that SCD patients may be at increased risk for
psychological problems [10,37–40]. For instance, the
occurrence of painful and unpredictable pain episodes
and intermittent hospitalizations associated with SCD
may lead to a sense of hopelessness and loss of control
in living with the disease. Also, the use of pain medica-
tions (including opioids) and frequent visits to emergency
rooms and/or hospitals expose SCD patients to being
stereotyped as a “drug addict” that, in turn, may
cause them to feel self-conscious at being stigmatized
[24,40].
Self-disclosure about SCD-related issues (including the
occurrence of pain episodes) may assist SCD patients to
gain information about their illness and to provide insight
about coping with health problems, including lowering
depression and stigma self-consciousness about being an
SCD patient. Also, talking with others about SCD-related
pain episodes may increase self-efficacy in dealing with
the disease and with pain episodes when they occur. For
instance, it has been found that SCD patients who are
socially isolated are more likely to experience a negative
affect [41]. There is also research [42] suggesting that
patients who find benefits associated with living with a
disease (such as being more accepting of things, bringing
family members closer together) report greater psycho-
logical adjustment.
Research Question 3: How Is Talking to Others about
Sickle Cell Pain Associated with Managing a Future
Sickle Pain Episode?
It has been reported that socially isolated SCD patients are
less likely to utilize medical services [41]. Given that
socially isolated SCD patients might be less likely to self-
disclose, we wanted to consider how self-disclosure
about SCD-related pain episodes was related to
willingness to seek medical help with a sickle cell pain
episode. In addition, talking with significant others may
provide insight into how to manage SCD pain episodes as
well as who to count on when needing assistance. Hence,
self-disclosure might be related to the use of different
methods to cope with sickle cell pain in the future




A convenience sample of 73 African American SCD
patients (30 men and 43 women) participated in this
cross-sectional survey. The sample size was determined
by the availability of participants for this preliminary study.
Most participants had been diagnosed with HbSS, and a
smaller number were diagnosed with HbSC and sickle
beta thalassemia. Participants were recruited for a ques-
tionnaire study focusing on the social and personal effects
of living with SCD. Participants were asked to describe
with whom they talked about their experiences with sickle
cell pain, how they felt psychologically living with SCD,
and how they coped with pain episodes. Participants were
recruited from among patients at two SCD clinics: Eastern
Virginia Medical School (Norfolk, Virginia) and Virginia
Commonwealth University/Medical College of Virginia
(Richmond, Virginia), from June 2008 through December
2008. The research was approved by the Institutional
Review Boards of Old Dominion University, Eastern
Virginia Medical School, and Virginia Commonwealth
University/Medical College of Virginia. See Tables 1 and 2
for background information about our participants, includ-
ing details about their demographic characteristics and
SCD pain-related experiences in the last 12 months. Three
patients declined to participate because they had time
constraints. No one refused to participate because of the
nature of the study.
Procedure
Participants were recruited at two SCD clinics for a study
on “Social Issues in Living with Sickle Cell Disease.” Pro-
spective participants were asked to complete a question-
naire focusing on to whom they talked, about pain-related
issues in dealing with SCD (e.g., family, friends, health care
providers), and whether it was helpful to talk with these
others about “pain-related thoughts and feelings.” One of
the investigators (a psychologist who was unaffiliated with
the SCD clinics) conducted the recruitment, and he also
presented the instructions for completing the question-
naire to all the participants. If SCD patients consented to
participate, then they proceeded to a private location in
the health care facility to complete the paper-and-pencil
questionnaires following a routine appointment with their
medical health care provider. To insure anonymity, partici-
pants did not identify themselves by name on the ques-
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Questionnaire Measures
Demographic Information and Pain Experiences
Participants first provided demographic information (e.g.,
age, gender, income, specific SCD diagnosis), and then,
they completed an adapted version of Gil’s [43] Structured
Pain Interview. Participants filled out a paper-and-pencil
questionnaire that included questions on number, dura-
tion, and intensity of pain episodes; ways of coping with
sickle cell pain; and frequency of visits to an emergency
room, hospital, and/or physician for pain.
Talking to Others about Sickle Cell Pain
Participants were asked to identify to whom they had
talked when they experienced sickle cell pain episodes in
the last 12 months. Participants were provided with a list
of significant others, including mother, father, close friend,
intimate partner, primary care physician, and God. Partici-
pants answered “yes” or “no” if they talked to each “other”
about the pain episodes. Participants were asked to
restrict their responses to others who were alive or who
had a role in their life (e.g., a coworker if the participant
were employed or a minister if the person was involved in
a religious organization). Then, participants rated how fully
they had talked to each of these persons and how helpful
it was to talk to each of them about what happened during
the sickle cell episode(s). Ratings were made on a 5-point
scale, ranging from 1 (least) to 5 (most).
Several measures were included to assess depressive
symptoms, SCD-related stigma, benefit finding in living
with SCD, and pain efficacy dealing with sickle cell pain
episodes. These measures are described below.
Centers for Epidemiological Studies-Depression
Scale
The measure of depressive symptoms experienced during
the previous week was based on responses to an 11-item
version of the Centers for Epidemiological Studies-
Depression Scale (CES-D) [44]. Sample items included, “I













African American 73 (100)
Education level
High school or less 25 (34.2)
At least some college 48 (65.8)
Total annual household income
Less than $30,000 46 (64.8)
Over $30,001 25 (35.2)
Marital status
Married 26 (35.6)
Intimate partner 25 (34.2)
Single, widowed, or divorced 22 (30.1)
SCD diagnosis
Sickle cell anemia 50 (69.4)
Sickle cell hgb (HbSC) 13 (18.1)
Sickle beta thalassemia 8 (11.1)
Don’t know 1 (1.4)
SCD pain management
Heat application 45 (61.6)
Rest and stop activity 44 (60.3)
Opioids 64 (87.7)
Nonopioids 25 (34.2)
No medications 1 (1.4)
I did not have pain 1 (1.4)
Reports of physical complications and SCD pain management
were based on events in the previous 12 months. The percent-
ages reported in Table 1 are based on the total number of
participants (N = 73), except for the demographic information
about household income (N = 71), SCD diagnosis (N = 72),
and work status (N = 67) where there were some missing data
that was not included in the percentage computation.
HbSC = hemoglobin SC; SCD = sickle cell disease.
Table 2 Means and standard deviations of pain
experiences in the previous 12 months
Variable N M SD Range
Number of pain episodes 67 8.61 11.42 0–60
Duration of pain episodes
(days)
65 6.16 6.51 0–42
Intensity of pain episodes (from
0 indicating “no pain” to 10
indicating “as bad as it can
be”)
70 7.64 2.21 0–10
Number of ER visits due to
pain episodes
71 2.38 3.11 0–15
Number of hospitalizations due
to pain episodes
72 1.72 2.20 0–11
Duration of hospital stays due
to pain episodes (days)
61 5.31 4.23 0–15
Number of physician visits due
to pain episodes
71 6.28 7.91 0–52
“N” refers to the number of participants who answered each
question. We should note that women, compared with men,
reported more pain episodes (means of 10.00 vs 6.56,
P < 0.05) and fewer visits to a physician due to pain episodes
(means of 4.42 vs 9.14, P < 0.05). There were no differences
between men and women on the other measures in this table.
ER = emergency room; SD = standard deviation.
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failure,” and “I felt sad.” Ratings were made on a 4-point
scale, from 1 (rarely or none of the time) to 4 (most of the
time). Scores across individual items were averaged with
higher scores indicating a greater number of depressive
symptoms experienced in the last 7 days. Cronbach’s
alpha was 0.86.
Stigma Consciousness Questionnaire
Self-consciousness about being stigmatized or stereo-
typed, based on the SCD diagnosis, was measured using
an adapted nine-item version of Pinel’s Stigma Con-
sciousness Questionnaire [45]. Sample items included,
“When interacting with someone who doesn’t have sickle
cell disease, I feel like they interpret all my behaviors in
terms of the fact that I have sickle cell,” and “Most people
have a lot more negative thoughts than they actually
express about sickle cell disease.” Ratings were made on
a 7-point scale, ranging from 0 (strongly disagree) to 6
(strongly agree), and items were averaged so that higher
scores reflected higher stigma consciousness associated
with SCD. Cronbach’s alpha was 0.73 for our sample.
Benefits Finding Questionnaire
A modified, 17-item version of Antoni et al.’s [42] Benefits
Finding Questionnaire assessed patients’ perceptions of
benefits associated with the SCD diagnosis. Sample
statements included, “Having sickle cell has led me to be
more accepting of things,” “Having sickle cell has shown
me that all people need to be loved,” and “Having sickle
cell has brought my family closer together.” Responses
were made on a 5-point scale, ranging from 1 (not at all) to
5 (extremely) with higher scores indicating the perception
that more benefits accrued from living with SCD.
Cronbach’s alpha for our participants was 0.93.
Pain Self-Efficacy Questionnaire
The 10-item Pain Self-Efficacy Questionnaire [46]
assessed participants’ confidence to engage in various
activities (e.g., enjoy things, cope without medication, live
a normal lifestyle, socialize with friends and family) despite
sickle cell pain. Ratings were made on a 7-point scale,
ranging from 0 (not at all confident) to 6 (completely con-
fident), with higher scores indicating higher pain self-
efficacy. Sample items included, “I can still accomplish
most of my goals in life despite the pain” and “I can do
some form of work despite the pain (“work” includes
housework, paid and unpaid work). Cronbach’s alpha for
the pain self-efficacy scale was 0.91.
How Participants Anticipate Managing Sickle
Cell Pain
Six different methods of coping with a future pain episode
were listed. These methods included the following: “I
would go to a doctor,” “I would go to a hospital or to an
emergency room,” “I would take non-narcotic pain medi-
cation,” “I would take narcotic pain medications,” “I would
try to get help from family or friends,” and “I would try to
hold off doing something hoping the pain goes away or
improves.” Ratings were made for each statement on a
4-point scale, ranging from 1 (I would not do this at all) to
4 (I would do this a lot).
Statistical Analysis
Means and standard deviations were calculated for most
of the items in the survey. Pearson product–moment cor-
relations were calculated between the amount of talking
with others about sickle cell pain episodes and the
endorsement of pain management techniques in dealing
with a pain episode in the future and between the help-
fulness of talking with others about sickle cell pain epi-
sodes and the endorsement of pain management
techniques in dealing with a pain episode in the future.
Also, t-tests for independent samples were used to
compare men with women with respect to their experi-
ences with pain and the strategies they used to cope with
it, while t-tests for paired samples were calculated to
determine if there were differences in the extent to which
patients talk to various others and the degree to which
such communications were helpful. All statistical analyses
were performed using SPSS Version 20.0 (SPSS Inc.,
Chicago, IL, USA).
To simplify the statistical analyses, we combined the data
for several categories of “others.” We combined the
ratings for mother and father to create a “parent” category
on the amount and helpfulness of disclosure. Similarly,
ratings for brother and sister were combined into a
“sibling” category, primary physician and primary nurse
were combined into “primary medical providers” category,
and intimate partner and close friend were combined into
an “intimate partner/close friend” category. We also limited
these analyses on amount and helpfulness of disclosure to
categories of “others” for whom we had a substantial
number of observations, that is, parents, siblings, intimate




The demographic characteristics of the participants are
summarized in Table 1. Our sample was quite similar to
that of the PiSCES Project (Pain in Sickle Cell Epidemi-
ology Study) with respect to age (mean of 35.12 for our
sample; 34.15 for the PiSCES sample), somewhat more
likely to have at least some college (65.8% for our
sample; 49.1% for the PiSCES sample), and somewhat
more likely to be married (35.6% for our sample; 23.9%
for the PiSCES sample) [10,47].
Our participants may have experienced fewer pain epi-
sodes than those in the PiSCES sample. In this survey,
participants reported an average of 8.61 episodes over
the previous 12 months, whereas the PiSCES participants
reported an average of 8.87 episodes over the previous 6
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reported by the PiSCES participants, after adjusting for
time, may be a consequence of the difference in the
specifics of the question. We asked participants to recall
the number of pain episodes they had experienced over
the previous 12 months, while McClish et al. [47] had
participants complete daily diaries for up to 6 months. The
results regarding pain episodes and the attempts to deal
with them can be found in Table 2.
Research Question 1: To Whom and How Fully Do
SCD Patients Talk to Others about Recent
Experiences with Sickle Cell Pain and How Helpful Is
It to Talk About These Pain-Related Events?
Table 3 summarizes data describing who in participants’
social networks knew about their SCD diagnosis. Gener-
ally speaking, most or all people in participants’ social
network knew about their diagnosis. On the other hand,
Table 3 documents considerable variability in who the par-
ticipants talked to about pain episodes that happened in
the previous 12 months. There was a high percentage of
patients who talked about SCD pain episodes to their
primary physician, God, mother, intimate partner, close
friend, primary nurse, counselor/psychologist, and
employer/supervisor. For these categories of others, the
percentage of participants who talked about their pain
episodes ranged from 72.3% to 91.7%. Fewer patients,
ranging from 23.4% to 54.3%, talked about their pain
episodes to father, brother, casual friend, minister/clergy,
dentist, and coworker. There was an intermediate
percentage of participants who talked about SCD pain
episodes to their sister (63.2%).
Because the age of the participant might influence to
whom they talked (younger participants may be more
likely to have living parents), we examined the relationship
between age and how fully participants talked with the
various categories of others. The only significant correla-
tions were between age and amount of disclosure and
helpfulness of disclosure about pain episodes within the
previous 12 months with primary medical providers
(r = 0.30, P < 0.05; r = 0.38, P < 0.01, respectively).
Next, we examined how fully participants self-disclosed
to others about sickle cell pain episodes and the help-
fulness of such talks that occurred in the last 12 months.
We looked for differences among categories of people to
whom participants disclosed or the degree to which it
was helpful to talk to them. The results of these analyses
can be found in Table 4. Participants talked more fully
about their thoughts and feelings about pain episodes to
God and to their primary medical providers than to either
their parents, siblings, or their intimate partner/close
friends. There was no difference in the level of self-
disclosure to God vs primary medical providers about
the sickle cell pain episodes. Also, there was no differ-
ence in the level of self-disclosure about pain episodes
among parents, siblings, and intimate partners/
close friends. The same pattern of results was found
when we compared participants’ ratings of helpfulness
Table 3 Number and percentage of participants’ social network members who knew about their SCD
diagnosis and to whom they talked about sickle cell episode(s) during the previous 12 months
Variable
Number and Percentage of Particular
Others in Participants’ Networks Who
Knew about Their SCD Diagnosis
Number and Percentage of
Participants Who Talked to a
Particular Other about Pain Episode(s)
N % N %
Mother 65/65 100 55/65 84.6
Father 45/46 97.8 25/46 54.3
Brother 55/55 100 30/55 54.5
Sister 56/57 98.2 36/57 63.2
Intimate partner 61/62 98.4 51/62 82.3
Close friend 68/69 98.6 52/69 75.4
Casual friend 52/63 82.5 24/63 38.1
Primary physician 72/72 100 66/72 91.7
Primary nurse 65/65 100 47/65 72.3
Dentist 41/47 87.2 11/47 23.4
Employer/supervisor at work 23/23 100 20/23 87.0
Coworker 23/23 100 11/23 47.8
Counselor/psychologist 9/9 100 7/9 77.8
Minister/clergy 49/61 80.3 21/61 34.4
God — — 63/70 90.0
The denominator term in the N column represents the total number of participants who reported having a particular other in their
social network.
SCD = sickle cell disease; — = We did not ask participants if God knew about their illness.
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of talking to various others about sickle cell pain epi-
sodes. It was significantly more helpful for participants
to talk with God and/or primary medical providers
than to parents, siblings, and intimate partner/close
friends.
Research Question 2: How Is Talking to Others about
Sickle Cell Pain Related to Psychological Adjustment
for SCD Patients?
We examined the relationship between level of, and help-
fulness, of self-disclosure to parents, siblings, intimate
partner/close friends, primary medical providers, and God
with depressive symptoms, stigma consciousness,
benefit finding, and pain self-efficacy. Our expectation that
amount of self-disclosure would be associated with posi-
tive psychological consequences was generally con-
firmed. Amount and helpfulness of talking with God about
pain episodes were negatively related to frequency of
depressive symptoms (rs = −0.41, P < 0.01, and −0.54,
P < 0.01, respectively). Also, amount and helpfulness of
talking with God were positively related to pain self-
efficacy (rs = 0.28, P < 0.05, and 0.32, P < 0.05, respec-
tively). Thus, amount and helpfulness of talking with God
were related to lower frequency of depressive symptoms
and to higher confidence in managing life’s activities
despite sickle cell pain. We also found that amount and
helpfulness of talking with parents about pain episodes
were associated with lower SCD-related stigma self-
consciousness (rs = −0.34, P < 0.05, and −0.29,
P < 0.05, respectively). Participants who talked more fully
about their SCD pain episodes to parents were less self-
conscious about being stigmatized or stereotyped by
SCD. Finally, helpfulness in talking to siblings (r = 0.31,
P < 0.05) as well as to intimate partner/close friends
(r = 0.35, P < 0.01) about pain episodes was positively
associated with finding benefits in living with SCD. Higher
helpfulness in talking to siblings and to intimate partner/
close friend about sickle cell pain episodes was associ-
ated with endorsing more benefits associated with a SCD
diagnosis.
Research Question 3: How Is Talking to Others about
Sickle Cell Pain Associated with Managing a Future
Sickle Pain Episode?
Tables 5 and 6 present the bivariate correlations between
the amount and helpfulness in talking about pain episodes
to significant others and participants’ anticipated
responses to sickle cell pain episodes that might happen
in the future. Our predictions were generally supported.
Amount and helpfulness of talking with parents were posi-
tively related with getting help from family and friends in
response to a pain episode. Importantly, amount of talking
about pain episodes to siblings, intimate partner/close
friend, primary medical providers, and to God was also
associated with going to a doctor in the event of a future
pain episode. We also found that helpfulness in talking
with siblings, intimate partner/close friend, and primary
medical providers was related with willingness to go to a
doctor if a pain episode were to occur. Finally, helpfulness
in talking with an intimate partner/close friend about pre-
vious pain episodes was related to willingness to take
opioids to manage SCD pain in the future.
Discussion
The present study provided descriptive data about to
whom SCD patients talk about recent sickle cell pain
episodes, how fully they talk to others about these pain
episodes, and how helpful it was to talk about these
pain events to various others. The research also allowed
us to examine the relationships between how fully and
how helpful it was to talk with others about sickle cell pain
episodes and participants’ psychological adjustment and
anticipated coping with sickle cell pain in the future.
In discussing the results, we should first mention that
despite the fact that most people in patients’ social net-
works had knowledge of their SCD diagnosis, there was a
considerable diversity in “who” participants talked to
about their sickle cell pain episodes. Most patients iden-
tified their primary physician, God, mother, intimate
partner, close friend, primary care nurse, counselor/
Table 4 Means and standard deviations for amount and helpfulness of talking to particular others
Variable M and SD (N) Variable M and SD (N)
Amount of disclosure to: Helpfulness of disclosure
Parents 3.49a (1.29) (57) Parents 3.22a (1.46) (57)
Siblings 3.35a (1.40) (49) Siblings 3.32a (1.45) (49)
Intimate partner/close friend 3.84a (1.18) (64) Intimate partner/close friend 3.48a (1.36) (63)
Primary medical providers 4.39b (.77) (64) Primary medical providers 4.41b (.81) (64)
God 4.64b (.92) (59) God 4.57b (.96) (58)
The P value for the paired samples t-tests (P = 0.005) in each column was based on a Bonferroni correction (0.05 divided by 10
comparisons). Means that do not share a common subscript in a column are significantly different from one another. The N in
parentheses represents the number of observations for each measure. The ratings were made on a 5-point scale with 1 labeled as
“least” and 5 labeled as “most.”
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psychologist, and employer/supervisor at work as
someone with whom they talked about a sickle cell pain
episode that they experienced in the last 12 months.
Participants were less likely to talk about a sickle cell pain
episode with a father, brother, casual friend, minister/
clergy, a coworker, or a dentist. On the other hand,
patients reported talking more fully and that it was more
helpful to talk with God and/or a primary medical provider
(i.e., a physician or nurse) about sickle cell pain episodes
in contrast to their parents, siblings, and/or an intimate
partner/close friend. These results document the possible
range of significant others (including God) with whom
individuals talk about sickle cell pain. However, the results
also indicate that SCD patients make a distinction among
various others in terms of how fully and how helpful it may
be to talk about sickle cell pain episodes when these pain
events occur.
The results were modest, albeit suggestive, about the
associations between amount and helpfulness in talking to
particular others about sickle cell pain episodes and par-
ticipants’ psychologist adjustment. Participants were less
self-conscious about being stigmatized by SCD if they
talked more fully to their parents about sickle cell pain and
if they perceived that talking to them had been helpful.
There was no other association between the amount and
helpfulness of talking about sickle cell pain episodes to
any others in predicting SCD-related stigma. These results
suggest the possible role of open and supportive talk
between children with SCD and their parents in combating
concerns about being the target of SCD-related stereo-
types. Interestingly, helpfulness of talk with siblings and
intimate partners/close friend was positively associated
with finding benefits with SCD disease. It may be that the
responsiveness and support provided by siblings, intimate
Table 5 Bivariate correlations between the amount of talking with others about sickle cell pain episodes
and the endorsement of pain management techniques in dealing with a pain episode in the future
Variable







Go to doctor 0.19 (57) 0.41** (49) 0.35** (64) 0.33** (64) 0.26* (59)
Hospital or ER 0.16 (57) 0.24 (49) 0.33** (64) 0.17 (64) 0.05 (59)
Nonopioids 0.19 (57) 0.20 (49) −0.02 (63) 0.01 (64) −0.10 (58)
Take opioids −0.03 (57) −0.05 (49) 0.16 (64) −0.08 (64) −0.09 (59)
Get help from family or friends 0.30* (57) 0.13 (49) 0.12 (64) 0.07 (64) 0.15 (59)
Hold off doing something 0.02 (57) 0.12 (49) 0.07 (64) 0.06 (64) −0.04 (59)
*P < 0.05; **P < 0.01.
The number in parentheses represents the number of observations in computing each bivariate correlation.
ER = emergency room.
Table 6 Bivariate correlations between the helpfulness of talking with others about sickle cell pain
episodes and the endorsement of pain management techniques in dealing with a pain episode in
the future
Variable







Go to doctor 0.09 (57) 0.31* (49) 0.31* (63) 0.26* (64) 0.11 (58)
Hospital or ER 0.12 (57) 0.21 (49) 0.37** (63) 0.16 (64) −0.02 (58)
Nonopioids 0.24 (57) 0.33* (49) 0.06 (62) −0.04 (64) −0.17 (57)
Take opioids 0.11 (57) 0.04 (49) 0.32** (63) −0.12 (20) 0.03 (58)
Get help from family or friends 0.40** (57) 0.27 (49) 0.19 (63) 0.17 (64) 0.19 (58)
Hold off doing something −0.09 (57) −0.04 (49) 0.00 (63) 0.03 (64) −0.07 (58)
*P < 0.05; **P < 0.01.
The number in parentheses represents the number of observations in computing each bivariate correlation.
ER = emergency room.
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partners, and close friends shine a positive light on the
possibilities for personal growth and a high quality of life
despite the challenges and adversity that SCD patients
confront living with this disease.
Religious and spiritual activities (e.g., attendance at reli-
gious services, prayer, reading the Bible and religious
books) assume an important role in the lives of African
Americans [48]. Hence, it is not surprising that the amount
and helpfulness of talking to God were associated with
lower depression and higher pain self-efficacy. When SCD
patients talk fully to God about their experiences with pain
and when this talk is perceived to be helpful, patients may
feel more empowered and “in control” [20].
We should also note the positive association between
amount of talking with siblings, intimate partners/close
friend, primary medical providers (i.e., physicians and
nurses), and toGod andparticipants’ willingness to contact
a physician in the event of a future pain episode. A similar
pattern was found between helpfulness in talking about
recent pain episodes to siblings, intimate partner/close
friend, and primarymedical providers and going to a doctor
in case of a future pain episode. Although the results are
cross sectional, they suggest that how fully one talked and
the helpfulness in talking with others about what happened
during recent pain episodes may either alleviate patients’
concerns about contacting a physician in the event of a
future sickle cell pain episode and/or it may strengthen
patients resolve to problem solve (by contacting a physi-
cian) in the event of a possible medical emergency.
We must be cautious about the clinical implications of the
results because of its correlational nature. Nevertheless,
the results indicate that SCD disclosure is, for many
patients, a frequently used and helpful behavior in coping
with pain episodes. On the other hand, there are some
participants who decided not to talk about their thoughts
and feelings about SCD pain episodes to others or who
did not find SCD disclosure to be helpful. It might be useful
for SCD patients (particularly those who perceive that
there are barriers in talking with members of their social
network about SCD) to consider participating in a support
group with other SCD patients. Illness support groups
provide participants with the opportunity to tell and hear
stories about how group members are coping with their
health problems [49]. These groups provide mutual
support for patients and, potentially (in the case of SCD
patients), may give them a better understanding of how to
cope with SCD pain episodes as well as how to live with
this disease generally. We noted in the introduction that
writing about stressful experiences (i.e., expressive self-
disclosure) has beneficial effects for mental and physical
health [24]. A few studies even indicate that expressive
writing concerning health problems affects how well
someone copes with these issues (including positive
changes in how people feel about their illness) among
cancer patients and in self-reports of lower pain intensity
among chronic pelvic pain patients [50–52]. In the
absence of someone to talk to about sickle cell-related
issues, SCD patients might be encouraged (perhaps with
monitoring and feedback from a health professional) to
write about their deepest thoughts and feelings about
SCD. Expressive writing about SCD might be useful in
changing how SCD patients think about their illness and
possibly improve their skills and self-efficacy in coping with
SCD-related health problems.
We should note several limitations of the research. First,
the data are cross sectional. We cannot infer cause and
effect conclusions based on our results. It would be
important to conduct prospective research examining
how previous experiences in talking with various others
about sickle cell pain might predict future reports about
SCD patients’ psychological adjustment and how these
patients are coping with the disease. Second, we have a
relatively small sample of SCD patients in our study. It
would be important to replicate the research with a larger
number of participants to increase statistical power.
Despite these limitations, our results suggest important
avenues for future research in examining how SCD
patients cope with this disease and the nature of self-
disclosures they make. In particular, our participants
report that they talk relatively fully with their primary
medical providers and with God and that such self-
disclosures are particularly helpful. Interestingly, the
amount and helpfulness in talking with parents about
sickle cell pain episodes may play a unique role in reduc-
ing patients’ self-consciousness about being the target of
SCD-related stigma, and amount and helpfulness in
talking about pain episodes to God may empower
patients so that they experience fewer depressive symp-
toms. Thus, our findings suggest how talking with “signifi-
cant others” (parents, God, intimate partner/close friend
as well as medical care providers) about sickle cell pain
episodes may influence SCD patients’ quality of life.
We have not focused in this research on how participants
might have differed in the types of SCD disclosure about
pain episodes. For instance, we don’t know how often
SCD disclosure was used to express frustration about a
pain episode as opposed to, say, using SCD disclosure to
gain others’ assistance in planning how to cope with
future pain episodes. Future research should examine the
reasons generated for SCD disclosure to significant others
as well as how the content of SCD disclosure might be
more or less beneficial in coping with pain episodes. It
would also be of interest to note what types of responses
to SCD disclosures are perceived as helpful or unhelpful.
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